Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRibociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial.AuthorsO’Shaughnessy, Joyce; Petrakova, Katarina; Sonke, Gabe S.; Conte, Pierfranco; Arteaga, Carlos L.; Cameron, David A.; Hart, Lowell L.; Villanueva, Cristian; Jakobsen, Erik; Beck, Joseph T.; Lindquist, Deborah; Souami, Farida; Mondal, Shoubhik; Germa, Caroline; Hortobagyi, Gabriel N.PublicationBreast Cancer Research & Treatment, 2018, Vol 168, Issue 1, p127ISSN0167-6806Publication typeArticleDOI10.1007/s10549-017-4518-8